v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Treasury Stock, at cost
Beginning balance (in shares) at Dec. 31, 2023 82,527,609          
Beginning balance at Dec. 31, 2023 $ 187,885          
Ending balance (in shares) at Mar. 31, 2024 82,527,609          
Ending balance at Mar. 31, 2024 $ 187,885          
Beginning balance (in shares) at Dec. 31, 2023   4,755,141        
Beginning balance at Dec. 31, 2023 56,103 $ 5 $ 1,696,612 $ (14,110) $ (1,396,420) $ (229,984)
Increase (Decrease) in Stockholders' Equity            
Net loss (1,054)       (1,054)  
Convertible redeemable preferred stock dividends [1] (4,240)       (4,240)  
Restricted stock units distributed (in shares)   7,780        
Exercise of Common Stock options (in shares)   33        
Payments for taxes related to net share settlement of equity awards (in shares)   (2,684)        
Payments for taxes related to net share settlement of equity awards (46)   (46)      
Amortization of stock-based compensation 681   681      
Settlement of restricted stock unit liability 1,895   1,895      
Foreign currency translation adjustment (1,987)     (1,987)    
Other (in shares)   (39)        
Ending balance (in shares) at Mar. 31, 2024   4,760,231        
Ending balance at Mar. 31, 2024 $ 51,352 $ 5 1,699,142 (16,097) (1,401,714) (229,984)
Beginning balance (in shares) at Dec. 31, 2024 95,784,903          
Beginning balance at Dec. 31, 2024 $ 207,470          
Ending balance (in shares) at Mar. 31, 2025 95,784,903          
Ending balance at Mar. 31, 2025 $ 207,470          
Beginning balance (in shares) at Dec. 31, 2024 4,890,575 4,890,575        
Beginning balance at Dec. 31, 2024 $ (8,263) $ 5 1,714,052 (18,068) (1,474,268) (229,984)
Increase (Decrease) in Stockholders' Equity            
Net loss (3,993)       (3,993)  
Convertible redeemable preferred stock dividends [1] (4,439)       (4,439)  
Restricted stock units distributed (in shares)   22,511        
Amortization of stock-based compensation 284   284      
Settlement of restricted stock unit liability 314   314      
Foreign currency translation adjustment $ 2,639     2,639    
Ending balance (in shares) at Mar. 31, 2025 4,913,086 4,913,086        
Ending balance at Mar. 31, 2025 $ (13,458) $ 5 $ 1,714,650 $ (15,429) $ (1,482,700) $ (229,984)
[1] Transactions for these line items were exclusively with related parties. Refer to Footnote 4, Convertible Redeemable Preferred Stock and Stockholders' Equity (Deficit) and Footnote 8, Related Party Transactions.